Prothena Corporation plc (NASDAQ: PRTA) kicked off on Monday, up 11.42% from the previous trading day, before settling in for the closing price of $5.08. Over the past 52 weeks, PRTA has traded in a range of $4.32-$25.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 178.00%. While this was happening, its average annual earnings per share was recorded -62.11%. With a float of $42.32 million, this company’s outstanding shares have now reached $53.83 million.
Let’s determine the extent of company efficiency that accounts for 163 employees. In terms of profitability, gross margin is 57.64%, operating margin of -100.49%, and the pretax margin is -84.0%.
Prothena Corporation plc (PRTA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Prothena Corporation plc is 21.38%, while institutional ownership is 70.13%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.81 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -62.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.31% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Take a look at Prothena Corporation plc’s (PRTA) current performance indicators. Last quarter, stock had a quick ratio of 9.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -1.04 in the next quarter and is forecasted to reach -3.07 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Looking closely at Prothena Corporation plc (NASDAQ: PRTA), its last 5-days average volume was 1.03 million, which is a jump from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 66.38%. Additionally, its Average True Range was 0.49.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 10.85%, which indicates a significant decrease from 92.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.42% in the past 14 days, which was lower than the 84.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.53, while its 200-day Moving Average is $13.76. However, in the short run, Prothena Corporation plc’s stock first resistance to watch stands at $5.86. Second resistance stands at $6.05. The third major resistance level sits at $6.34. If the price goes on to break the first support level at $5.38, it is likely to go to the next support level at $5.09. Now, if the price goes above the second support level, the third support stands at $4.90.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
The company with the Market Capitalisation of 304.66 million has total of 53,827K Shares Outstanding. Its annual sales at the moment are 135,160 K in contrast with the sum of -122,310 K annual income. Company’s last quarter sales were recorded 2,830 K and last quarter income was -60,200 K.
